Early deficits in an in vitro striatal microcircuit model carrying the Parkinson's GBA-N370S mutation.
Do QB. et al, (2024), NPJ Parkinsons Dis, 10
What we can learn from iPSC-derived cellular models of Parkinson's disease.
Caiazza MC. et al, (2020), 252, 3 - 25
Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F. et al, (2019), Hum Mol Genet, 28, 2001 - 2013
Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
Lang C. et al, (2019), Cell Stem Cell, 24, 93 - 106.e6
Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
Sandor C. et al, (2017), Hum Mol Genet, 26, 552 - 566
ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
Fernandes HJR. et al, (2016), Stem Cell Reports, 6, 342 - 356
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
Protter D. et al, (2012), Parkinsons Dis, 2012